Inquis Medical

Focus: Inquis Medical is a public-stage biotechnology company focused on venous thromboembolism treatment, specifically developing thrombectomy solutions for pulmonary embolism. The company is headquartered in Menlo Park, California with minimal disclosed operational scale.

Respiratory Unknown

Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago

Funding Stage

PUBLIC

Open Jobs

About Inquis Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Inquis Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Thrombectomy

Pulmonary Embolism

N/A

Clinical Trials (1)

NCT05907564Aventus Thrombectomy System Pulmonary Embolism Clinical Study

N/A

Help build intelligence for Inquis Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on a focused, specialized therapeutic area (venous thromboembolism) with potential unmet medical need
Public company status provides potential liquidity and transparency relative to private-stage peers
Early-stage pipeline position offers the chance to shape development strategy from inception

Watch Out For

Extremely limited hiring activity (only 1 active job posting) signals minimal growth or capital deployment currently
No disclosed financials, publications, or recent news raises transparency and visibility concerns for career progression
Single clinical trial in portfolio and pre-revenue status indicate very early execution phase with execution risk

Generated by Claude from Inquis Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.